Eun Kyung Lee, Min Joo Kim, Seung Heon Kang, Bon Seok Koo, Kyungsik Kim, Mijin Kim, Bo Hyun Kim, Ji-hoon Kim, Shinje Moon, Kyorim Back, Young Shin Song, Jong-hyuk Ahn, Hwa Young Ahn, Ho-Ryun Won, Won Sang Yoo, Min Kyoung Lee, Jeongmin Lee, Ji Ye Lee, Kyong Yeun Jung, Chan Kwon Jung, Yoon Young Cho, Dong-Jun Lim, Sun Wook Kim, Young Joo Park, Dong Gyu Na, Jee Soo Kim
Endocrinol Metab. 2025;40(3):307-341. Published online June 24, 2025
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.
Citations
Citations to this article as recorded by
Feasibility and Safety of Active Surveillance in Subcapsular Thyroid Nodules with High Suspicion for Malignancy Yan Hu, Wei Zhou, Lu Zhang, Weiwei Zhan Ultrasound in Medicine & Biology.2026; 52(4): 816. CrossRef
Combined Ultrasound and MRI Assessment in Patients Undergoing Reoperation for Recurrent Papillary Thyroid Carcinoma: Oncological Outcomes and Surgical Safety Zimei Tang, Jie Liu, Rong Wang, Gang Tian, Anwen Ren, Jiexiao Li, Yiran Wang, Wen Yang, Peng Sun, Tao Huang, Ximeng Zhang, Jie Ming Current Oncology.2026; 33(2): 98. CrossRef
Multidisciplinary team diagnosis and treatment of well-differentiated thyroid carcinoma: current landscape and future prospects Yuanyuan Li, Peijie Wang, Jiaxin Cao, Haiyan Liu The Oncologist.2026;[Epub] CrossRef
Optimal cutoff value of fine-needle aspiration thyroglobulin of metastatic lymph node in thyroid cancer patients Yang Yang, Xianfeng Jiang European Journal of Surgical Oncology.2025; 51(11): 110428. CrossRef
Low-risk thyroid cancer: surgery or active surveillance—an application of shared decision-making: a narrative review Min Joo Kim, Eun Kyung Lee, Sun Wook Cho, Yoo Hyung Kim, Kyu Eun Lee, Su-jin Kim, Woochul Kim, Eun-Jae Chung, Jungirl Seok, Yul Hwangbo, Young Ki Lee, Jinsun Jang, Junsun Ryu, Yuh-Seog Jung, Chang Hwan Ryu, Jae Hoon Moon, June Young Choi, Hyeong Won Yu, K Journal of the Korean Medical Association.2025; 68(9): 573. CrossRef
Background This study investigated the diagnostic performance of biopsy criteria in four society ultrasonography risk stratification systems (RSSs) for thyroid nodules, including the 2021 Korean (K)-Thyroid Imaging Reporting and Data System (TIRADS).
Methods The Ovid-MEDLINE, Embase, Cochrane, and KoreaMed databases were searched and a manual search was conducted to identify original articles investigating the diagnostic performance of biopsy criteria for thyroid nodules (≥1 cm) in four widely used society RSSs.
Results Eleven articles were included. The pooled sensitivity and specificity were 82% (95% confidence interval [CI], 74% to 87%) and 60% (95% CI, 52% to 67%) for the American College of Radiology (ACR)-TIRADS, 89% (95% CI, 85% to 93%) and 34% (95% CI, 26% to 42%) for the American Thyroid Association (ATA) system, 88% (95% CI, 81% to 92%) and 42% (95% CI, 22% to 67%) for the European (EU)-TIRADS, and 96% (95% CI, 94% to 97%) and 21% (95% CI, 17% to 25%) for the 2016 K-TIRADS. The sensitivity and specificity were 76% (95% CI, 74% to 79%) and 50% (95% CI, 49% to 52%) for the 2021 K-TIRADS1.5 (1.5-cm size cut-off for intermediate-suspicion nodules). The pooled unnecessary biopsy rates of the ACR-TIRADS, ATA system, EU-TIRADS, and 2016 K-TIRADS were 41% (95% CI, 32% to 49%), 65% (95% CI, 56% to 74%), 68% (95% CI, 60% to 75%), and 79% (95% CI, 74% to 83%), respectively. The unnecessary biopsy rate was 50% (95% CI, 47% to 53%) for the 2021 K-TIRADS1.5.
Conclusion The unnecessary biopsy rate of the 2021 K-TIRADS1.5 was substantially lower than that of the 2016 K-TIRADS and comparable to that of the ACR-TIRADS. The 2021 K-TIRADS may help reduce potential harm due to unnecessary biopsies.
Citations
Citations to this article as recorded by
Enhancing diagnostic accuracy of thyroid nodules: integrating self-learning and artificial intelligence in clinical training Daham Kim, Yoon-a Hwang, Youngsook Kim, Hye Sun Lee, Eunjung Lee, Hyunju Lee, Jung Hyun Yoon, Vivian Youngjean Park, Miribi Rho, Jiyoung Yoon, Si Eun Lee, Jin Young Kwak Endocrine.2025; 88(3): 766. CrossRef
Interobserver agreement between artificial intelligence models in the thyroid imaging and reporting data system (TIRADS) assessment of thyroid nodules Andrea Leoncini, Pierpaolo Trimboli Endocrine.2025; 89(1): 197. CrossRef
A comparative study of Chinese and ACR-TIRADS diagnostic accuracy in small thyroid nodule risk evaluation Rasha Nadeem Ahmed, Maysaloon Shaman Saeed, Nazar M. T. Jawhar, Mohamed Tarek El-Diasty, Noha Yahia Ebaid, Mostafa Mohamad Assy Egyptian Journal of Radiology and Nuclear Medicine.2025;[Epub] CrossRef
Risk Stratification of Thyroid Nodules 10 mm in Diameter or Less: Strength and Pitfalls of the Ultrasonographic Assessment From a Cross‐Sectional Study Giuseppe Lisco, Anna De Tullio, Vito Angelo Giagulli, Giuseppina Renzulli, Vincenzo Triggiani, Suraiya Saleem International Journal of Endocrinology.2025;[Epub] CrossRef
Ultrasound Risk Stratification of Autonomously Functioning Thyroid Nodules: Cine Loop Video Sequences Versus Static Image Captures Larissa Rosenbaum, Martin Freesmeyer, Tabea Nikola Schmidt, Christian Kühnel, Falk Gühne, Philipp Seifert Diagnostics.2025; 15(19): 2525. CrossRef
Interobserver Agreement Among Thyroid Ultrasound Operators in Defining Thyroid Nodules as Subcapsular Pierpaolo Trimboli, Enrico Papini, Jörg Bojunga, Chiara Camponovo, Maurilio Deandrea, Antonio Giangregorio, Lauro Gianola, Giorgio Grani, Rinaldo Guglielmi, Andrea Frasoldati, Fabian Pitoia, Gilles Russ, Cosimo Durante, Andrea Leoncini Thyroid®.2025; 35(10): 1198. CrossRef
Accuracy of ultrasound in predicting thyroid malignancy: a comparative analysis of the ACR TI-RADS and ATA risk stratification systems Shaza Samargandy, Aliaa H. Ghoneim Archives of Endocrinology and Metabolism.2024;[Epub] CrossRef
Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules 2024 Young Joo Park, Eun Kyung Lee, Young Shin Song, Su Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung, International Journal of Thyroidology.2024; 17(1): 208. CrossRef
Individual Ultrasonographic Characteristics of Thyroid Nodules and Their Cytopathological Correlation to Determine Malignancy Risk Miguel Ángel Castilla Villanueva, Dania Guadalupe Solis Cano, Ana Amador Martínez, Marco Antonio Téliz Meneses, Jesús Baquera-Heredia, Cesar Eduardo Vallin Orozco, Mónica Loya Ceballos Cureus.2024;[Epub] CrossRef
Improving the diagnostic performance of inexperienced readers for thyroid nodules through digital self-learning and artificial intelligence assistance Si Eun Lee, Hye Jung Kim, Hae Kyoung Jung, Jin Hyang Jung, Jae-Han Jeon, Jin Hee Lee, Hanpyo Hong, Eun Jung Lee, Daham Kim, Jin Young Kwak Frontiers in Endocrinology.2024;[Epub] CrossRef
Systemic therapy for differentiated thyroid cancer with distant metastasis Eun Kyung Lee Journal of the Korean Medical Association.2024; 67(7): 484. CrossRef
To Screen or Not to Screen? Do Joon Park Endocrinology and Metabolism.2023; 38(1): 69. CrossRef
The 2017 United States Preventive Services Task Force Recommendation for Thyroid Cancer Screening Is No Longer the Gold Standard Ka Hee Yi Endocrinology and Metabolism.2023; 38(1): 72. CrossRef
Thyroid Cancer Screening: How to Maximize Its Benefits and Minimize Its Harms Jung Hwan Baek Endocrinology and Metabolism.2023; 38(1): 75. CrossRef
2023 Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules Young Joo Park, Eun Kyung Lee, Young Shin Song, Soo Hwan Kang, Bon Seok Koo, Sun Wook Kim, Dong Gyu Na, Seung-Kuk Baek, So Won Oh, Min Kyoung Lee, Sang-Woo Lee, Young Ah Lee, Yong Sang Lee, Ji Ye Lee, Dong-Jun Lim, Leehi Joo, Yuh-Seog Jung, Chan Kwon Jung International Journal of Thyroidology.2023; 16(1): 1. CrossRef
Evaluation of the Appropriateness of Thyroid Fine-Needle Aspiration Lairce Cristina Ribeiro Brito, Iara Beatriz De Carvalho Botêlho, Lanna Matos Silva Fernandes, Nayze Lucena Sangreman Aldeman, Uziel Nunes Silva International Journal for Innovation Education and Research.2023; 11(6): 8. CrossRef
Background Although radiofrequency ablation (RFA) is a safe treatment for thyroid tumors, nerve damage is a frequent complication. A previous retrospective study suggested that an injection of cold 5% dextrose in water (5% DW) can reduce nerve damage during RFA. This study validated the efficacy of injecting cold 5% DW for management of nerve damage during RFA.
Methods Between November 2017 and December 2018, 242 patients underwent 291 RFA sessions for treatment of benign thyroid nodules or recurrent thyroid cancers. Using a standardized technique, cold (0°C to 4°C) 5% DW was immediately injected around the damaged nerve into patients with any symptoms suggesting nerve damage. The incidence of nerve damage, the volume of 5% DW injected, symptom recovery time and the incidence of permanent nerve damage were evaluated.
Results Nineteen patients experienced nerve damage symptoms related to 21 RFA sessions, including 17 patients during 19 sessions and two patients on the day after two sessions. Patients with nerve damage symptoms detected during RFA were treated by injection of a mean 41 mL (range, 3 to 260) cold 5% DW, but the two patients who experienced symptoms the next day did not receive cold 5% DW injections. Immediate recovery was observed after 15 RFA sessions in 14 patients. No patient experienced permanent nerve damage.
Conclusion Injection of cold 5% DW is effective in managing nerve damage during RFA of thyroid lesions.
Citations
Citations to this article as recorded by
Vocal Fold Immobility After Radiofrequency Ablation of Thyroid Nodules: A Survey of Laryngologists and an Algorithm for Periprocedural Voice Assessment Vaninder Kaur Dhillon, Catherine Fiona Sinclair Head & Neck.2026; 48(3): 821. CrossRef
International expert consensus on thermal ablation for benign thyroid nodules (2025 Edition) Shi-Liang Cao, Shu-Rong Wang, Ji-Hoon Kim, Gregory W. Randolph, Song-Yuan Yu, Giovanni Mauri, Wei-Che Lin, Gang Dong, Kai-Lun Cheng, Bülent Çekiç, Song-Song Wu, Ingo Janssen, Hossam A. Ghazi, Jian-Qin Guo, Gerardo Amabile, Carlos N. Lehn, Jun-Feng He, Raf International Journal of Surgery.2026;[Epub] CrossRef
Direct Ice Packing for Voice Changes During Thyroid Radiofrequency Ablation: A Retrospective Case Series Mei-Chen Yeh, Wei-Shin Yu, Hsiang-Lin Lee, Yu-Shen Lee, Kai-Lun Cheng, Osamu Isozaki Case Reports in Endocrinology.2026;[Epub] CrossRef
Radiofrequency Ablation for Primary Thyroid Cancer Iram Hussain Endocrine Practice.2026;[Epub] CrossRef
Thyroid Radiofrequency Ablation‐Thermal Effects on Recurrent Laryngeal Nerve Using Continuous Intraoperative Neuromonitoring Animal Model Tzu‐Yen Huang, Shih‐Wei Wang, Hsin‐Yi Tseng, Gregory W. Randolph, Gianlorenzo Dionigi, Yi‐Chu Lin, Cheng‐Hsun Chuang, I‐Cheng Lu, Chih‐Hung Lin, Leong‐Perng Chan, Feng‐Yu Chiang, Che‐Wei Wu Otolaryngology–Head and Neck Surgery.2025; 172(1): 63. CrossRef
Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline Eun Ju Ha, Min Kyoung Lee, Jung Hwan Baek, Hyun Kyung Lim, Hye Shin Ahn, Seon Mi Baek, Yoon Jung Choi, Sae Rom Chung, Ji-hoon Kim, Jae Ho Shin, Ji Ye Lee, Min Ji Hong, Hyun Jin Kim, Leehi Joo, Soo Yeon Hahn, So Lyung Jung, Chang Yoon Lee, Jeong Hyun Lee, Korean Journal of Radiology.2025; 26(1): 10. CrossRef
Complications in chemical and thermal ablation of parathyroid lesions: a systematic review and meta-analysis So Yeong Jeong, Se Jin Cho, Jung Hwan Baek European Radiology.2025; 35(12): 7738. CrossRef
Long-Term Outcomes of Radiofrequency Ablation in Patients with Low-Risk Papillary Thyroid Microcarcinoma Hunjong Lim, Min Joo Kim Endocrinology and Metabolism.2025; 40(3): 385. CrossRef
Which Intraoperative Monitoring Method More Accurately Predicts Voice Change After Thyroid Nodule Ablation: Transcutaneous Laryngeal Ultrasonography Versus Subjective Voice Assessment Xiaomin Guo, Bowen Zheng, Jinfen Wang, Tao Wu, Tinghui Yin, Yufan Lian, Lei Tan, Yanping Ma, Rui Guo, Yuting He, Jie Ren Ultrasound in Medicine & Biology.2025; 51(10): 1846. CrossRef
Scholarly Dialogue on Risk to the Recurrent Laryngeal Nerve with Thermal Ablation Procedures: A Reflection on Empirical Practices Marika Russell, Che-Wei Wu, Tzu-Yen Huang, R. Michael Tuttle, Peter A. Kopp, Jung Hwan Baek, Lisa A. Orloff, Julia Noel, Joseph Scharpf, Peter Angelos, Kyung Tae, Jeong Seon Park, Elizabeth Cottrill, Victoria Banuchi, MaryBeth Cunnane, Maurilio Deandrea, Thyroid®.2025; 35(11): 1221. CrossRef
The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules Meghal Shah, Catherine McManus Surgical Clinics of North America.2024; 104(4): 779. CrossRef
Recurrent laryngeal nerve monitoring by flexible laryngoscopy during thyroid radiofrequency ablation in the awake patient Marsida Teliti, Antonio Occhini, Rodolfo Fonte, Laura Croce, Benedetto Calì, Federica Antonella Ripepi, Andrea Carbone, Mario Rotondi, Spyridon Chytiris Frontiers in Endocrinology.2024;[Epub] CrossRef
Long-term clinical outcomes of thermal ablation for benign thyroid nodules and unresolved issues: a comprehensive systematic review So Yeong Jeong, Jung Hwan Baek La radiologia medica.2024; 130(1): 111. CrossRef
Clinical and Economic Evaluation of Ultrasound-Guided Radiofrequency Ablation vs. Parathyroidectomy for Patients with Primary Hyperparathyroidism: A Cohort Study Hui-hui Chai, Zhan-jing Dai, Bai Xu, Qiao-hong Hu, Hong-feng He, Ying Xin, Wen-wen Yue, Cheng-zhong Peng Academic Radiology.2023; 30(11): 2647. CrossRef
Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves’ disease, a pilot study Man Him Matrix Fung, Brian Hung Hin Lang European Radiology.2023; 33(9): 6534. CrossRef
Radiofrequency Ablation of Cervical Thyroid Cancer Metastases—Experience of Endocrinology Practices in the United States Shahzad Ahmad, Jules Aljammal, Ian Orozco, Sheharyar Raashid, Fizza Zulfiqar, Sean P Nikravan, Iram Hussain Journal of the Endocrine Society.2023;[Epub] CrossRef
Radiofrequency ablation of benign thyroid nodules: the value of anterolateral hydrodissection So Yeong Jeong, Jung Hwan Baek, Sae Rom Chung, Young Jun Choi, Ki-Wook Chung, Tae Yong Kim, Jeong Hyun Lee Ultrasonography.2023; 42(3): 432. CrossRef
Effective and Safe Application of Radiofrequency Ablation for Benign Thyroid Nodules Jin Yong Sung Journal of the Korean Society of Radiology.2023; 84(5): 985. CrossRef
Assessment of thyroid-specific quality of life in patients with benign symptomatic thyroid nodules treated with radiofrequency or ethanol ablation: a prospective multicenter study So Yeong Jeong, Eun Ju Ha, Jung Hwan Baek, Tae Yong Kim, Yu-Mi Lee, Jeong Hyun Lee, Jeonghun Lee Ultrasonography.2022; 41(1): 204. CrossRef
Management of Recurrent Laryngeal Nerve Injury During Radiofrequency Ablation of Thyroid Nodules Jules Aljammal, Iram Hussain, Shahzad Ahmad AACE Clinical Case Reports.2022; 8(2): 102. CrossRef
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy Sae Rom Chung, Jung Hwan Baek, Young Jun Choi, Jeong Hyun Lee Current Oncology Reports.2022; 24(8): 1045. CrossRef
Improving Voice Outcomes after Thyroid Surgery and Ultrasound-Guided Ablation Procedures Pia Pace-Asciak, Jon O. Russell, Ralph P. Tufano Frontiers in Surgery.2022;[Epub] CrossRef
Using Intra‐Operative Laryngeal Ultrasonography as a Real‐Time Tool in Assessing Vocal Cord Function During Radiofrequency Ablation of the Thyroid Gland Matrix Man Him Fung, Brian Hung Hin Lang World Journal of Surgery.2022; 46(9): 2206. CrossRef
Long-term outcome of microwave ablation for benign thyroid nodules: Over 48-month follow-up study Jia-Rui Du, Wen-Hui Li, Cheng-Hai Quan, Hui Wang, Deng-Ke Teng Frontiers in Endocrinology.2022;[Epub] CrossRef
Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety Catherine F. Sinclair, Maria J. Téllez, Roberto Peláez-Cruz, Alba Díaz-Baamonde, Sedat Ulkatan The American Journal of Surgery.2021; 222(2): 354. CrossRef
Future Considerations and Directions for Thermal Ablative Technologies Jonathon Russell, Catherine F. Sinclair Current Otorhinolaryngology Reports.2021; 9(2): 210. CrossRef